tiprankstipranks

Josh Mandel-Brehm Insider Profile

4 Followers
Josh Mandel-Brehm, CEO, Director at CAMP4 Therapeutics Corporation, holds 284.97K shares in CAMP4 Therapeutics Corporation (Ticker: CAMP), holds ― shares in ProMIS Neurosciences (Ticker: PMN). Most recently, Josh Mandel-Brehm Bought ― shares of CAMP4 Therapeutics Corporation on Aug 05, 2026 for an estimated value of $10.81K.
tipranks
Josh Mandel-Brehm

Josh Mandel-Brehm
CAMP4 Therapeutics Corporation (CAMP)
CEO, Director

Ranked #38,183 out of 108,921 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+34.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
100.00%
0.00%
A breakdown of Josh Mandel-Brehm's holdings

Insider Roles

CAMP4 Therapeutics Corporation
(CAMP)
CEO, Director
ProMIS Neurosciences
(PMN)
Director
Roles that Josh Mandel-Brehm holds in companies

Most Profitable Insider Trade

Stock:
CAMP4 Therapeutics Corporation
(CAMP)
Rating:Informative Buy
Date:Sep 11, 2025 - Sep 11, 2026
Return:+58.60%
The most profitable trade made by Josh Mandel-Brehm

Josh Mandel-Brehm's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CAMP4 Therapeutics Corporation
Aug 05, 2026
CEO, Director
Informative Buy
10.81K
$1.24M
ProMIS Neurosciences
Director
List of latest transactions for each holding click on a transaction to see Josh Mandel-Brehm's performance on stock

Josh Mandel-Brehm insider profile FAQ

What is the percentage of profitable transactions made by Josh Mandel-Brehm?
The percentage of profitable transactions made by Josh Mandel-Brehm is 100%.
    What is the average return per transaction made by Josh Mandel-Brehm?
    The average return per transaction made by Josh Mandel-Brehm is 34.20%.
      What stocks does Josh Mandel-Brehm hold?
      Josh Mandel-Brehm holds: CAMP, PMN stocks.
        What was Josh Mandel-Brehm’s latest transaction?
        Josh Mandel-Brehm latest transaction was an Informative Buy of $10.81K.
          What was Josh Mandel-Brehm's most profitable transaction?
          Josh Mandel-Brehm’s most profitable transaction was an Informative Buy of CAMP stock on September 11, 2025. The return on the trade was 58.60%.
            What is Josh Mandel-Brehm's role in CAMP4 Therapeutics Corporation?
            Josh Mandel-Brehm's role in CAMP4 Therapeutics Corporation is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.